Your browser doesn't support javascript.
loading
Efficacy, safety and immunogenicity of GP2015, an etanercept biosimilar, compared with the reference etanercept in patients with moderate-to-severe rheumatoid arthritis: 24-week results from the comparative phase III, randomised, double-blind EQUIRA study.
Matucci-Cerinic, Marco; Allanore, Yannick; Kavanaugh, Arthur; Buch, Maya H; Schulze-Koops, Hendrik; Kucharz, Eugeniusz J; Woehling, Heike; Babic, Goran; Poetzl, Johann; Davis, Adanna; Schwebig, Arnd.
Afiliación
  • Matucci-Cerinic M; Department of Experimental and Clinical Medicine, Division of Rheumatology AOUC, University of Florence, Florence, Italy.
  • Allanore Y; Cochin Hospital, Rheumatology A Department, Paris Descartes University, Paris, France.
  • Kavanaugh A; UC San Diego School of Medicine, La Jolla, California, USA.
  • Buch MH; University of Leeds and NIHR Leeds Biomedical Research Centre, Leeds, UK.
  • Schulze-Koops H; Division of Rheumatology and Clinical Immunology, Department of Internal Medicine IV, Ludwig-Maximilians-University, Munich, Germany.
  • Kucharz EJ; Medical University of Silesia, Katowice, Poland.
  • Woehling H; Hexal AG, a Sandoz company, Holzkirchen, Germany.
  • Babic G; Hexal AG, a Sandoz company, Holzkirchen, Germany.
  • Poetzl J; Hexal AG, a Sandoz company, Holzkirchen, Germany.
  • Davis A; Sandoz Inc, Princeton, New Jersey, USA.
  • Schwebig A; Hexal AG, a Sandoz company, Holzkirchen, Germany.
RMD Open ; 4(2): e000757, 2018.
Article en En | MEDLINE | ID: mdl-30487998
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: RMD Open Año: 2018 Tipo del documento: Article País de afiliación: Italia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: RMD Open Año: 2018 Tipo del documento: Article País de afiliación: Italia